Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Heran Partners is a Belgium-based venture capital firm founded in 2019, focusing on life sciences and healthcare. The firm was established by a group of entrepreneurs and investors with expertise in scientific and technological innovation. They manage a portfolio of 15 companies, targeting investments primarily in Europe and the United Kingdom.
Heran Partners invests in seed, Series A, and Series B stages, targeting companies that aim to improve healthcare through innovative technology. They seek ventures with strong intellectual property and differentiated approaches that address unmet market needs. The firm emphasizes feasibility for disruptive innovation in the life sciences sector.
Notable portfolio companies include: Pharmacelera (Spain), which develops in-silico drug discovery technologies; Gynaia (Belgium), providing AI tools for women's health diagnostics; and Nuclivision (Belgium), enhancing nuclear imaging software solutions. Other companies include ImmuneSpec, Aspect Analytics, Amaron, Thirona, Hypervision Surgical, Broken String Biosciences, icometrix, LynxCare, ONTOFORCE, FOx Biosystems, UgenTec, PharmaFluidics, and BlueBee.
Submit through their form at https://heranpartners.com/contact or email info@heranpartners.com with your deck.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.